Hyaluronic Moisturizer
- Manufacturer
- Bentley Laboratories LLC
- Effective date
- 2024-10-16
- Label type
- HUMAN OTC DRUG LABEL
- Version
- 1
- Source
- full-release
- Hydrated at
- 2026-06-01 00:27:06
Label at a glance#
Contacts and useful links#
Label contents#
Full prescribing information#
OTC - ACTIVE INGREDIENT SECTION
Drug Facts
Active ingredients
Avobenzone 3%, Octinoxate 7.5%, Oxybenzone 5%
OTC - PURPOSE SECTION
Purpose
Sunscreen
INDICATIONS & USAGE SECTION
Uses ● helps prevent sunburn
● If used as directed with other sun protection measures (see Directions),
decreases the risk of skin cancer and early aging caused by the sun.
WARNINGS SECTION
Warnings
For external use only.
Do not use on damaged or broken skin.
Stop use and ask a doctor if rash occurs.
• When using this product keep out of eyes. Rinse with water to remove.
OTC - KEEP OUT OF REACH OF CHILDREN SECTION
Keep out of reach of children.
If product is swallowed, get medical help or contact a Poison Control Center right away.
DOSAGE & ADMINISTRATION SECTION
Directions
•apply liberally 15 minutes before sun exposure • use a water-resistant sunscreen if swimming or sweating •reapply at least every 2 hours
• children under 6 months: Ask a doctor •Sun Protection Measures. Spending time in the sun increases your risk of skin cancer and early aging. To decrease this risk, regularly use a sunscreen with a Broad Spectrum SPF value of 15 or higher and other sun protection measur es including:
• limit time in the sun, especially from 10 a.m. - 2 p.m. • Wear long-sleeved shirts, pants, hats, and sunglasses.
INACTIVE INGREDIENT SECTION
Inactive Ingredients Aqua (Water, Eau), Dimethicone, Butylene Glycol, Paraffinum Liquidum (Mineralil, Huile Minerale)
Sesamum Indicum (Sesame) Seed Oil, Ethylhexyl Methoxycrylene, Glyceryl Stearate SE, Glyceryl Isostearate, Stearic Acid, Sodium
Hyaluronate, C 10-30 Cholesterol/Lanosterol Esters, Ethylhexylglycerin, Parfum (Fragrance), Carbomer, Phenoxyethanol, Sodium Hydroxide, Yellow 5 (CI 19140)
OTHER SAFETY INFORMATION
Other information Protect this product from excessive heat and direct sun,
OTC - QUESTIONS SECTION
Questions or comments?Call 1-800-223-3728 M – F 9 a.m. – 5 p.m. EST or visit mariobadescu.com
Mario Badescu HYALURONIC MOISTURIZER SPF 15 product label
MARIO
BADESCU
SKIN CARE
Established 1967
MB
HYALURONIC MOISTURIZER
Store in a cool, dry place. 0001
Manufactured in the US with
globally-sourced ingredients.
Mario Badescu Skin Care,
New York, NY • (800) BADESCU
Leceur, Bulevardi 21, 00180
Helsinki FI / Plaza 1, Salford
M50 3UB, UK
order online at
mariobadescu.com
res
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 54111-182-01 | Hyaluronic Moisturizer | 59 mL in 1 BOTTLE | CREAM | 59 | 1 |
DailyMed Dashboard NDC Coverage#
Products#
Every source-derived product name is available through these pages.
- Hyaluronic Moisturizer
- Octinoxate, Oxybenzone. Avobenzone
- OCTINOXATE
- OXYBENZONE
- AVOBENZONE
- WATER
- DIMETHICONE
- BUTYLENE GLYCOL
- MINERAL OIL
- SESAME OIL
- ETHYLHEXYL METHOXYCRYLENE
- GLYCERYL STEARATE SE
- GLYCERYL ISOSTEARATE
- STEARIC ACID
- HYALURONATE SODIUM
- C10-30 CHOLESTEROL/LANOSTEROL ESTERS
- ETHYLHEXYLGLYCERIN
- CARBOMER HOMOPOLYMER, UNSPECIFIED TYPE
- PHENOXYETHANOL
- SODIUM HYDROXIDE
- FD&C YELLOW NO. 5
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 54111-182 | 54111-182-01 |
Ingredients#
Every source-derived ingredient row is available through these pages.
Source Document#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Hyaluronic Moisturizer | OCTINOXATE, OXYBENZONE. AVOBENZONE | Bentley Laboratories LLC | 88bd6dff-ba19-4f8f-9432-28398d24f1ab | 2024-10-16 | Warnings | 54111-182-01 54111-182 54111018201 075fb173-4ec4-47e7-b473-3dffc2df5b0a 88bd6dff-ba19-4f8f-9432-28398d24f1ab |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
